| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 8 |
| 1 | CARBOPLATIN | 5 |
| 2 | PEMETREXED DISODIUM | 5 |
| 3 | FLUOROURACIL | 2 |
| 4 | FLUOROURACIL CREAM, 0.5% | 2 |
| 5 | COLISTIMETHATE | 1 |
| 6 | COLISTIMETHATE SODIUM | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COLISTIMETHATE SODIUM | 1 | 0.0006 |
| 1 | PEMETREXED DISODIUM | 5 | 0.0001 |
| 2 | BEVACIZUMAB | 8 | 0.0001 |
| 3 | CARBOPLATIN | 5 | 0.0000 |
| 4 | FLUOROURACIL CREAM, 0.5% | 2 | 0.0000 |
| 5 | FLUOROURACIL | 2 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 8 |
| 1 | Platinum-based Drug [EPC] | 5 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 8 | 0.0000 |
| 1 | Platinum-based Drug [EPC] | 5 | 0.0000 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |